The National Cancer Institute has made clinical trial participation a top national priority and yet participant levels are still not perhaps where they could be. Yes, this is a big decision for any patient/physician to make as far as whether or not to enroll, but many trials are offering lifesaving...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
11-02-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Investors, health insurance, Pharma, Cancer, clinical trials, HMO, Pharmaceuticals, R and D, Drug Development, Cancer Institute
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-11-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests